Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/15/2025

Corticosteroid Dosing Guidelines

Introduction to Corticosteroid Therapy

  • The American College of Allergy, Asthma, and Immunology recommends methylprednisolone 60-80mg daily as a single dose for 5-10 days for acute asthma exacerbations 4, 1, 2
  • The British Association of Dermatologists suggests initial therapy of 60-100mg daily as a single dose for severe inflammatory conditions like Pemphigus Vulgaris 5, 6

Dosing Regimens

  • For adults with asthma exacerbations, the recommended dose is 60-80mg daily as a single dose for 5-10 days 4, 2
  • For pediatric patients, 1-2 mg/kg/day (maximum 60mg/day) in 2 divided doses for 3-10 days is recommended 4, 2
  • For severe inflammatory conditions, initial high-dose phase should continue until disease control is achieved, then taper by 5-10mg weekly initially, more slowly below 20mg daily 5, 6

Duration of Treatment

  • The standard duration for acute asthma exacerbations is 5-10 days, and treatment should continue until peak expiratory flow reaches 70% of predicted or personal best 1, 2, 4
  • For severe inflammatory conditions, the initial high-dose phase should continue until disease control is achieved, and the total treatment course may extend months to years depending on the condition 5, 6

Route of Administration

  • Oral administration is strongly preferred and equally effective as IV when gastrointestinal absorption is intact 7, 2
  • No advantage exists for IV over oral therapy in most situations, and IV route should be reserved for patients who are vomiting, severely ill, or have impaired GI absorption 4, 7, 2

Safety Monitoring

  • Short courses (5-10 days) have very low rates of serious adverse effects, but monitoring of glucose, blood pressure, and mood changes is still necessary 2, 1
  • For courses >2-3 weeks, implement osteoporosis prophylaxis per guidelines, and monitor for GI bleeding risk, especially in patients with prior GI bleeding history or on anticoagulants 5, 2